Alan D Kaye, Laxmaiah Manchikanti, Matthew B Novitch, Imran N Mungrue, Muhammad Anwar, Mark R Jones, Erik M Helander, Elyse M Cornett, Matthew R Eng, Jay S Grider, Michael E Harned, Ramsin M Benyamin, John R Swicegood, Thomas T Simopoulos, Salahadin Abdi, Richard D Urman, Timothy R Deer, Cyrus Bakhit, Mahendra Sanapati, Sairam Atluri, Ramarao Pasupuleti, Amol Soin, Sudhir Diwan, Ricardo Vallejo, Kenneth D Candido, Nebojsa Nick Knezevic, Douglas Beall, Sheri L Albers, Richard E Latchaw, Hari Prabhakar, Joshua A Hirsch
BACKGROUND: Interventional pain management involves diagnosis and treatment of chronic pain. This specialty utilizes minimally invasive procedures to target therapeutics to the central nervous system and the spinal column. A subset of patients encountered in interventional pain are medicated using anticoagulant or antithrombotic drugs to mitigate thrombosis risk. Since these drugs target the clotting system, bleeding risk is a consideration accompanying interventional procedures. Importantly, discontinuation of anticoagulant or antithrombotic drugs exposes underlying thrombosis risk, which can lead to significant morbidity and mortality especially in those with coronary artery or cerebrovascular disease...
January 2019: Pain Physician